euronanomed.net

  • Increase font size
  • Default font size
  • Decrease font size

euronanomed.net
 

Nanomedicine is the application of nanotechnology to medicine and healthcare. The field takes advantage of the physical, chemical and biological properties of materials at the nanometer scale to be used for diagnosis, treatment and follow-up of diseases. Given the immense potential impact of nanomedicine on public wellbeing and on economic growth, the field is of considerable strategic importance for Europe.

The EuroNanoMed ERA-NET initiative comprises 24 partners from 18 countries/regions. EuroNanoMed aims at fostering the competitiveness of European nanomedicine players through the support of trans-national collaborative and multidisciplinary Research and Technology Development (RTD) projects with participants from academia, clinical/public health communities, and industry (particularly small and medium-sized enterprises).
 

 

 

RESULTS OF THE 1ST CALL

DOWNLOAD PRESS RELEASE: EuroNanoMed promotes European collaborations and innovations in nanomedicine.

Following the recommendations of the Peer Review Panel that were based on overall quality assessment of all eligible applications received in response to the Joint Call, the Call Steering Committee of EuroNanoMed, at its meeting in Padova on October 16th, selected the following projects (listed according to the ranking by the Peer Review Panel):

 
ACRONYM
FULL TITLE
COORDINATOR
COORDINATING COUNTRY
1
DENANORNA
Dendrimers as nanovectors for targeted siRNA delivery in gene therapy
Ling Peng (Centre National Recherche Scientifique)
France
2
Nano4Neuro
Nano-Functionalised Implants for the Regenerative Treatment of Spinal Cord and Nerve Lesions
Burkhard Schlosshauer (Natural and Medical Sciences Institute at the University of Tübingen)
Germany
3
LYMPHOTARG
LYMPHONANOCARRIERS FOR THE TREATMENT OF METASTATIC CANCER
Maria José Alonso Fernández (University of Santiago de Compostela)
Spain
4
I-CARE
Integrative nano-Composites And Regeneration of the Eye
May Griffith (Linköpings University)
Sweden
5
EAREG
Ear Tissue Regeneration Using Human Cells and Novel Nano-Cellulose Scaffolds
Paul Gatenholm (Chalmers University of Technology)
Sweden
6
TARGET-PDT
Photo Dynamic Therapy using photosensitizer-doped targeted organic nanoparticles
Patrick Boisseau (CEA – Commissariat à l’énergie atomique)
France
7
DENPEPTHIV
Peptides-associated dendrimers in dendritic cells for the development of new nano-HIV vaccines
Mª Angeles Muñoz Fernández (Hospital General Universitario Gregorio Marañón)
Spain
8
NANOSTEM
Targeting Combined Therapy to Cancer Stem Cells
Simó Schwartz Jr (CIBER-BBN)
Spain

The final budget of each funded project partner is to be negotiated and specified by the relevant funding agency.

 

 

Latest News


Monday, 01 February 2010 09:00
Thursday, 29 October 2009 09:00
Wednesday, 28 October 2009 11:59
Show all news

Subscribe News Letters